RxDoctor Payments Data

Seth Rubin, MD

Obstetrics & Gynecology · Flemington, NJNPI 1023070422

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $15,180 of the $18,798 with a category attached, or 80.8%. Pfizer accounts for 98.6% of it on its own, with 9 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,798in general payments, 2019–2025

Across 29 payments — averaging $648.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$19K
  • GSK$104
  • AMAG Pharmaceuticals, Inc.$35
  • Therapeuticsmd, Inc.$30
  • Medtronic$24
  • Lupin Inc.$21
  • plus $47 from 4 others

What the payments were for

  • Speaking & faculty fees$15,18081%
  • Travel & lodging$2,61514%
  • Food & beverage$9685%
  • Education$350%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,798 in reported general payments places this provider in the 95th percentile of 1,242 obstetrics & gynecology providers in New Jersey.

See all obstetrics & gynecology providers in New Jersey

Medicare billing

Part B allowed, 2024
$58,111
Medicare patients
196
Services billed
788

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron35$29,952
ProliaDenosumab11$18,726
Estradiol57$7,508
Clobetasol Propionate38$962
Alendronate Sodium72$911
ValacyclovirValacyclovir Hcl14$541
Levothyroxine Sodium41$421
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip21$405
Oxybutynin Chloride ErOxybutynin Chloride13$373
Atorvastatin Calcium24$268
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$184
Fluconazole19$148
Fluoxetine Hcl11$136

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Flemington

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →